CYP2E1 rs2031920, COMT rs4680 Polymorphisms, Cigarette Smoking, Alcohol Use and Lung Cancer Risk in a Japanese Population

  • Kakino, Kenichi (Evaluation Center of Health and Nutrition Inc.) ;
  • Kiyohara, Chikako (Department of Preventive Medicine, Graduate School of Medical Sciences, Kyushu University) ;
  • Horiuchi, Takahiko (Department of Internal Medicine, Kyushu University Beppu Hospital) ;
  • Nakanishi, Yoichi (Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University)
  • Published : 2016.08.01


Background: Cytochrome P450 2E1 (CYP2E1) and catechol-O-methyltransferase (COMT) genes may contribute to susceptibility to lung cancer because of their critical involvement in mechanisms of carcinogenesis. Materials and Methods: We evaluated the role of CYP2E1 rs2031920 and COMT rs4680 in a case-control study involving 462 lung cancer cases and 379 controls in Japanese. Logistic regression was used to assess adjusted odds ratios (OR) and 95% confidence intervals (CI). Multiplicative and additive interactions with cigarette smoking or alcohol use were also examined. Results: Neither CYP2E1 rs2031920 nor COMT rs4680 was associated with lung cancer risk overall. However, smokers with the CC genotype of CYP2E1 rs2031920 (OR = 3.57, 95% CI = 2.26 - 5.63) presented a higher risk of lung cancer than those with at least one T allele (OR = 2.91, 95% CI = 1.70 - 4.98) as compared to never-smokers with at least one T allele (reference). Subjects with excessive drinking and the CC genotype of CYP2E1 rs2031920 had a significantly higher risk (OR = 2.22, 95% CI =1.39 - 3.56) than appropriate drinkers with at least one T allele. A similar tendency was observed between COMT rs4680 and either smoking or drinking habits. There were no multiplicative or additive interactions between the polymorphisms and either smoking or alcohol use. Conclusions: Our findings indicate that CYP2E1 rs2031920 and COMT rs4680 are not major contributors to lung cancer risk in our Japanese population. Future studies on the genetics of lung cancer in Japanese and their environment interactions are required.


Supported by : Ministry of Education, Culture, Sports, Science and Technology


  1. Alvik A, Haldorsen T, Lindemann R (2005). Consistency of reported alcohol use by pregnant women: anonymous versus confidential questionnaires with item nonresponse differences. Alcohol Clin Exp Res, 29, 1444-9.
  2. Andersson T, Alfredsson L, Kallberg H, et al (2005). Calculating measures of biological interaction. Eur J Epidemiol, 20, 575-9.
  3. Bagnardi V, Rota M, Botteri E, et al (2015). Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer, 112, 580-93.
  4. Ball P, Knuppen R (1980). Catecholoestrogens (2-and 4-hydroxyoestrogens): chemistry, biogenesis, metabolism, occurrence and physiological significance. Acta Endocrinol Suppl (Copenh), 232, 1-127.
  5. Bandera EV, Freudenheim JL, Vena JE (2001). Alcohol consumption and lung cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev, 10, 813-21.
  6. Benedetti A, Parent ME, Siemiatycki J (2009). Lifetime consumption of alcoholic beverages and risk of 13 types of cancer in men: results from a case-control study in Montreal. Cancer Detect Prev, 32, 352-62.
  7. Bountziouka V, Bathrellou E, Giotopoulou A, et al (2012). Development, repeatability and validity regarding energy and macronutrient intake of a semi-quantitative food frequency questionnaire: methodological considerations. Nutr Metab Cardiovasc Dis, 22, 659-67.
  8. Colilla S, Lerman C, Shields PG, et al (2005). Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenet Genomics, 15, 393-8.
  9. Cote ML, Yoo W, Wenzlaff AS, et al (2009). Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis, 30, 626-35.
  10. Doll R, Peto R (1981). The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst, 66, 1191-308.
  11. Hayashi S, Watanabe J, Kawajiri K (1991). Genetic polymorphisms in the 5’-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem, 110, 559-65.
  12. Hirata H, Hinoda Y, Okayama N, et al (2008). COMT polymorphisms affecting protein expression are risk factors for endometrial cancer. Mol Carcinog, 47, 768-74.
  13. Holman CD, English DR, Milne E, et al (1996). Meta-analysis of alcohol and all-cause mortality: a validation of NHMRC recommendations. Med J Aust, 164, 141-5.
  14. Iwahashi K, Miyatake R, Suwaki H, et al (1994). [Blood ethanol levels and the CTP2E1 C2 allele]. Arukoru Kenkyuto Yakubutsu Ison, 29, 190-4.
  15. Kalilani L, Atashili J (2006). Measuring additive interaction using odds ratios. Epidemiol Perspect Innov, 3, 5.
  16. Kauhanen J, Hallikainen T, Tuomainen TP, et al (2000). Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol Clin Exp Res, 24, 135-9.
  17. Kiyohara C, Horiuchi T, Takayama K, et al (2010). IL1B rs1143634 polymorphism, cigarette smoking, alcohol use, and lung cancer risk in a Japanese population. J Thorac Oncol, 5, 299-304.
  18. Lim WY, Chen Y, Chuah KL, et al (2012). Female reproductive factors, gene polymorphisms in the estrogen metabolism pathway, and risk of lung cancer in Chinese women. Am J Epidemiol, 175, 492-503.
  19. Ministry of Health, Labour and Welfare. Healthy Japan 21, Available:
  20. Munafo MR, Freathy RM, Ring SM, et al (2011). Association of COMT Val(108/158)Met genotype and cigarette smoking in pregnant women. Nicotine Tob Res, 13, 55-63.
  21. NCBI, Available: snp_ref.cgi?rs=4680.
  22. NCBI, Available: snp_ref.cgi?rs=2031920.
  23. Peng S, Tong X, Liu S, et al (2015). Association between the COMT 158 G/A polymorphism and lung cancer risk: a metaanalysis. Int J Clin Exp Med, 8, 17739-47.
  24. Percy C, van Holten V, Muir C 1990. International Classification of Diseases for Oncology (ICD-O), Geneva, Switzerland, World Health Organization.
  25. Redden DT, Shields PG, Epstein L, et al (2005). Catechol-Omethyl- transferase functional polymorphism and nicotine dependence: an evaluation of nonreplicated results. Cancer Epidemiol Biomarkers Prev, 14, 1384-9.
  26. Riegelman RK (2004). Interpretation. In 'Studying a Study and Testing a Test : How to Read the Medical Evidence. ', Eds Lippincott Williams & Wilkins, Philadelphia, PA, 50-7
  27. Rothman K 2002. Measuring interaction, New York, Oxford University Press.
  28. Sam CH, Skeaff S, Skidmore PM (2014). A comprehensive FFQ developed for use in New Zealand adults: reliability and validity for nutrient intakes. Public Health Nutr, 17, 287-96.
  29. Sun F, Tsuritani I, Yamada Y (2002). Contribution of genetic polymorphisms in ethanol-metabolizing enzymes to problem drinking behavior in middle-aged Japanese men. Behav Genet, 32, 229-36.
  30. Syvanen AC, Tilgmann C, Rinne J, et al (1997). Genetic polymorphism of catechol-O-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and parkinsonian patients in Finland. Pharmacogenetics, 7, 65-71.
  31. Tan X, Chen M (2014). Association between Catechol-Omethyltransferase rs4680 (G>A) polymorphism and lung cancer risk. Diagn Pathol, 9, 192.
  32. Uhl GR, Vandenbergh DJ, Rodriguez LA, et al (1998). Dopaminergic genes and substance abuse. Adv Pharmacol, 42, 1024-32.
  33. Ulusoy G, Arinc E, Adali O (2007). Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population. Arch Toxicol, 81, 711-8.
  34. van der Aalst CM, de Koning HJ (2016). Biochemical verification of the self-reported smoking status of screened male smokers of the Dutch-Belgian randomized controlled lung cancer screening trial. Lung Cancer, 94, 96-101.
  35. Watanabe J, Hayashi S, Kawajiri K (1994). Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5'-flanking region. J Biochem, 116, 321-6.
  36. Wong SL, Shields M, Leatherdale S, et al (2012). Assessment of validity of self-reported smoking status. Health Rep, 23, 47-53.
  37. World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: A Global Perspective. 1997. Washington DC, AICR.
  38. World Cancer Research Fund / American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. 2007. Washington DC, AICR.
  39. Ye XH, Song L, Peng L, et al (2015). Association between the CYP2E1 polymorphisms and lung cancer risk: a metaanalysis. Mol Genet Genomics, 290, 545-58.
  40. Zhai W, Feng R, Yang H, et al (2015). Note of clarification of data on the association between CYP2E1 RsaI polymorphism and lung cancer risk. Eur J Cancer, 51, 1650-5.
  41. Zhang JW, Yu WJ, Sheng XM, et al (2014). Association of CYP2E1 and NAT2 polymorphisms with lung cancer susceptibility among Mongolian and Han populations in the Inner Mongolian region. Asian Pac J Cancer Prev, 15, 9203-10.
  42. Zhang Y, Hua S, Zhang A, et al (2013). Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers. Clin Lung Cancer, 14, 45-9.
  43. Zienolddiny S, Campa D, Lind H, et al (2008). A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis, 29, 1164-9.